Patents by Inventor Anne O'Donnell

Anne O'Donnell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240076643
    Abstract: The disclosure provides a modified protein that is a combination of (i) an L-asparaginase and (ii) one or more (poly)peptide(s), wherein the (poly)peptide consists solely of proline and alanine amino acid residues, and methods of preparation and use thereof.
    Type: Application
    Filed: September 21, 2023
    Publication date: March 7, 2024
    Inventors: Lars Friedrich, Anne O'Donnell
  • Patent number: 11802279
    Abstract: The disclosure provides a modified protein that is a combination of (i) an L-asparaginase and (ii) one or more (poly)peptide(s), wherein the (poly)peptide consists solely of proline and alanine amino acid residues, and methods of preparation and use thereof.
    Type: Grant
    Filed: June 1, 2021
    Date of Patent: October 31, 2023
    Assignee: Jazz Pharmaceuticals Ireland Ltd.
    Inventors: Lars Friedrich, Anne O'Donnell
  • Publication number: 20220056430
    Abstract: The disclosure provides a modified protein that is a combination of (i) an L-asparaginase and (ii) one or more (poly)peptide(s), wherein the (poly)peptide consists solely of proline and alanine amino acid residues, and methods of preparation and use thereof.
    Type: Application
    Filed: June 1, 2021
    Publication date: February 24, 2022
    Inventors: Lars FRIEDRICH, Anne O'DONNELL
  • Publication number: 20190169589
    Abstract: The disclosure provides a modified protein that is a combination of (i) an L-asparaginase and (ii) one or more (poly)peptide(s), wherein the (poly)peptide consists solely of proline and alanine amino acid residues, and methods of preparation and use thereof.
    Type: Application
    Filed: December 19, 2018
    Publication date: June 6, 2019
    Applicants: XL-Protein GmbH, Jazz Pharmaceutical Ireland Limited
    Inventors: Lars Friedrich, Anne O'Donnell
  • Patent number: 10174302
    Abstract: The disclosure provides a modified protein that is a combination of (i) an L-asparaginase and (ii) one or more (poly)peptide(s), wherein the (poly)peptide consists solely of proline and alanine amino acid residues, and methods of preparation and use thereof.
    Type: Grant
    Filed: August 7, 2017
    Date of Patent: January 8, 2019
    Assignees: XL-protein GmbH, Jazz Pharmaceuticals Ireland Limited
    Inventors: Lars Friedrich, Anne O'Donnell
  • Publication number: 20180371446
    Abstract: The disclosure provides a modified protein that is a combination of (i) an L-asparaginase and (ii) one or more (poly)peptide(s), wherein the (poly)peptide consists solely of proline and alanine amino acid residues, and methods of preparation and use thereof.
    Type: Application
    Filed: August 7, 2017
    Publication date: December 27, 2018
    Applicants: XL-protein GmbH, Jazz Pharmaceuticals Ireland Limited
    Inventors: Lars Friedrich, Anne O'Donnell